SCOTT DAVID LEVINE, MD
Osteopathic Medicine in Orlando, FL
License number
Florida ME55318
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
7350 Sandlake Cmns, Orlando, FL 32819
Phone
(407) 363-1515
(407) 363-9538 (Fax)
(407) 351-9040
(407) 363-9538 (Fax)
(407) 351-9040
Personal information
See more information about SCOTT DAVID LEVINE at radaris.comName
Address
Phone
5049 Northern Lights Dr, Greenacres, FL 33463
522 Pinellas Bayway S APT 11, Tierra Verde, FL 33715
48 Wickliffe Dr, Naples, FL 34110
4845 Dove Cross Dr, Lakeland, FL 33810
444 NE 2Nd Ave #8, Fort Lauderdale, FL 33301
Professional information
See more information about SCOTT DAVID LEVINE at trustoria.com
Dr. Scott D Levine, Orlando FL - MD (Doctor of Medicine)
Dr. Scott D Levine, Orlando FL - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
Mid Florida Medical Specialists
7350 Sandlake Commons Blvd SUITE 22, Orlando 32819
(407) 363-1515 (Phone)
7350 Sandlake Commons Blvd SUITE 22, Orlando 32819
(407) 363-1515 (Phone)
Procedures:
Age Management (Anti-Aging Medicine), Botox Injections, Diet & Exercise Counseling, Internal Medicine, Juvederm, Nutrition, Physicals, Weight Loss, Wellness, Woman's Health & Wellness
Conditions:
Botox Injections, Internal Medicine, Nutrition, Obesity, Physicals, Weight Loss
Certifications:
Internal Medicine, 1988
Awards:
Healthgrades Honor Roll, , ,
Languages:
English, Spanish
Hospitals:
Mid Florida Medical Specialists
7350 Sandlake Commons Blvd SUITE 22, Orlando 32819
Florida Hospital Orlando
601 East Rollins St, Orlando 32803
Orlando Regional Medical Center - Lucerne Pavilion
818 Main Ln, Orlando 32801
7350 Sandlake Commons Blvd SUITE 22, Orlando 32819
Florida Hospital Orlando
601 East Rollins St, Orlando 32803
Orlando Regional Medical Center - Lucerne Pavilion
818 Main Ln, Orlando 32801
Philosophy:
Dr. Levine acts as an advocate and educator for his patients. He is extremely thorough and is known as the medical detective by his patients. Dr. Levine is proud of his care record in that no patient has ever suffered from a heart attack, stroke, or kidney failure under his care. He specializes in preventing, finding, and treating conditions that are silent but will ruin your longevity and freedom. His advanced prevention strategies have made his patients the healthiest in the country. He is committed to investigating what conditions you have and then customizing a plan to optimize your health and longevity.
In order to provide this excellence in care, Dr. Levine is not part of any insurance panels that require doctors conform to their demands.
Education:
Medical School
Wayne State University School Of Medicine
Graduated: 1985
UCLA San Fernando Vly Prg
Graduated: 1988
Wayne State University School Of Medicine
Graduated: 1985
UCLA San Fernando Vly Prg
Graduated: 1988
Scott David Levine, Orlando FL
Scott David Levine, Orlando FL
Specialties:
Internist
Address:
7350 Sandlake Commons Blvd, Orlando, FL 32819
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine
Ultra-High Fiber Supplement And Method Of Reducing Weight Cardiovascular Risks And Ingested Toxins.
Ultra-High Fiber Supplement And Method Of Reducing Weight Cardiovascular Risks And Ingested Toxins.
US Patent:
7030092, Apr 18, 2006
Filed:
Aug 24, 2001
Appl. No.:
09/939385
Inventors:
Scott Levine - Orlando FL, US
Assignee:
Small Giant L.L.C. - Orlando FL
International Classification:
A01N 43/04, A61K 31/70, A23L 2/00
US Classification:
514 23, 514 25, 426 72, 426 74, 426590, 426615, 426658
Abstract:
An improved ultra-high fiber supplement that promotes satiety, caloric reduction, and weight loss. The supplement comprises guar, oat, psyllium, locust bean gum, pectin, green tea, multi-anthocyanadins, pyridoxine, and folic acid. It improves cardiovascular health and reduces cardiovascular inflammation and the risk of heart disease. The addition of antioxidants, including green tea, improves weight loss, and general and cardiovascular health. Also it reduces serum lipoprotein oxidation and risk of free-radical related diseases. Additional benefits include the lowering of plasma homocysteine by the addition of folic acid and pyridoxine. Consumption of the supplement aids in reducing absorption and assimilation of ingested toxins. A method of providing an ultra-high fiber comestible that is highly palatable and can be used to supplement nutrition and to manage and prevent diet-related diseases is disclosed. Further embodiments increase fiber and other nutrients in the diet and helps manage and prevent all diet-related diseases.
Ultra-High Fiber Supplement And Method Of Cancer Reduction
Ultra-High Fiber Supplement And Method Of Cancer Reduction
US Patent:
2004009, May 20, 2004
Filed:
Nov 10, 2003
Appl. No.:
10/704308
Inventors:
Scott Levine - Orlando FL, US
International Classification:
A61K035/78, A61K047/00
US Classification:
424/439000, 424/738000, 424/750000
Abstract:
An improved ultra-high fiber supplement that promotes satiety, caloric reduction, and weight loss. The supplement comprises guar, oat, psyllium, locust bean gum, pectin, green tea, multi-anthocyanadins, pyridoxine, and folic acid. It improves cardiovascular health and reduces cardiovascular inflammation and the risk of heart disease. The addition of antioxidants, including green tea, improves weight loss, and general and cardiovascular health. Also it reduces serum lipoprotein oxidation and risk of free-radical related diseases. Additional benefits include the lowering of plasma homocysteine by the addition of folic acid and pyridoxine. Consumption of the supplement aids in reducing absorption and assimilation of ingested toxins. A method of providing an ultra-high fiber comestible that is highly palatable and can be used to supplement nutrition and to manage and prevent diet-related diseases is disclosed. Further embodiments increase fiber and other nutrients in the diet and helps manage and prevent all diet-related diseases.
Ultra-High Fiber Supplement And Method Of Reducing Weight, Cardiovascular Risks And Ingested Toxins
Ultra-High Fiber Supplement And Method Of Reducing Weight, Cardiovascular Risks And Ingested Toxins
US Patent:
7977319, Jul 12, 2011
Filed:
Apr 3, 2006
Appl. No.:
11/395712
Inventors:
Scott David Levine - Orlando FL, US
International Classification:
A01N 43/04, A61K 31/70, A23L 2/00
US Classification:
514 23, 514 25, 426 72, 426 74, 426590, 426615, 426658
Abstract:
An improved ultra-high fiber supplement that promotes satiety, caloric reduction, and weight loss. The supplement comprises guar, oat, psyllium, locust bean gum, pectin, green tea, multi-anthocyanadins, pyridoxine, and folic acid. The supplement can exist as a liquid, semi-solid, or solid comestible. It improves cardiovascular health and reduces cardiovascular inflammation and the risk of heart disease. The addition of antioxidants, including green tea, improves weight loss, and general and cardiovascular health. Also it reduces serum lipoprotein oxidation and risk of free-radical related diseases. Consumption of the supplement aids in reducing absorption and assimilation of ingested toxins. A method of providing an ultra-high fiber comestible that is highly palatable and can be used to supplement nutrition and to manage and prevent diet-related diseases is disclosed. Further embodiments increase fiber and other nutrients in the diet and helps manage and prevent all diet-related diseases.